Shares of Large-cap health care company The Cooper Companies moved 0.5% this afternoon, and are now trading at $373.26 per share. The average analyst target price for the stock is $407.38.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.
Based on its trailing earning per share of 5.79, The Cooper Companies has a trailing 12 month Price to Earnings (P/E) ratio of 64.5 COO has a forward P/E ratio of 26.0.
The company has a price to earnings growth (PEG) ratio of 2.9. A number between 0 and 1 could mean that the market is undervaluing The Cooper Companies' estimated growth potential
The Company May Be Profitable, but Its Balance Sheet Is Highly Leveraged
| 2017-12-22 | 2018-12-21 | 2019-12-20 | 2020-12-11 | 2021-12-10 | 2022-12-09 | |
|---|---|---|---|---|---|---|
| Revenue (MM) | $2,139 | $2,533 | $2,653 | $2,431 | $2,922 | $3,308 |
| Gross Margins | 64.0% | 64.0% | 66.0% | 63.0% | 67.0% | 65.0% |
| Operating Margins | 20% | 16% | 20% | 13% | 17% | 15% |
| Net Margins | 17.0% | 6.0% | 18.0% | 10.0% | 101.0% | 12.0% |
| Net Income (MM) | $373 | $140 | $467 | $238 | $2,945 | $386 |
| Net Interest Expense (MM) | -$33 | -$83 | -$68 | -$37 | -$23 | -$57 |
| Depreciation & Amort. (MM) | -$188 | -$275 | -$281 | -$287 | -$309 | -$346 |
| Earnings Per Share | $7.52 | $2.81 | $9.33 | $4.81 | $59.25 | $7.76 |
| EPS Growth | n/a | -62.63% | 232.03% | -48.45% | 1131.81% | -86.9% |
| Diluted Shares (MM) | 50 | 50 | 50 | 50 | 50 | 50 |
| Free Cash Flow (MM) | $721 | $862 | $1,005 | $797 | $953 | $934 |
| Capital Expenditures (MM) | -$127 | -$194 | -$292 | -$310 | -$214 | -$242 |
| Net Current Assets (MM) | -$730 | -$1,714 | -$1,483 | -$1,638 | -$1,199 | -$2,784 |
| Long Term Debt (MM) | $1,149 | $1,986 | $1,263 | $1,384 | $1,398 | $2,351 |
| Net Debt / EBITDA | 1.76 | 2.87 | 2.15 | 2.8 | 1.7 | 3.08 |
The Cooper Companies has weak revenue growth and a flat capital expenditure trend, irregular cash flows, and just enough current assets to cover current liabilities. We also note that the company benefits from wider gross margins than its peer group and average operating margins with a stable trend. However, the firm suffers from declining EPS growth and a highly leveraged balance sheet.
